Search
InnoCare Pharma-B (2591.HK) Sees Over 270% Surge in Dark Pool Trading on Futu
2025-08-14 /
Read about 0 minute
Author：小编
Shares of InnoCare Pharma-B soared by more than 270% in dark pool trading on Futu, with a quoted price reaching HK$70.05. The company, which specializes in the treatment of metabolic diseases, boasts a core product named Ispaglumide α. This innovative drug is designed to treat obesity and metabolic dysfunction-associated fatty liver disease (MASH). In its global offering, InnoCare Pharma-B successfully raised approximately HK$610 million in net proceeds. These funds will primarily be allocated towards clinical trials and the commercialization of its core products.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
